CompaniesTryp Therapeutics

Tryp Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

19

By Phase

PHASE2: 2PHASE1: 1

By Status

RECRUITING: 1WITHDRAWN: 1COMPLETED: 1

Recent Trials

NCT06206265Lead Sponsor
Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)
PHASE2Recruiting
14 participants
Started: Jan 17, 2024 · Completed: Mar 1, 2026
NCT05467761Collaborator
Bioavailability Study of Psilocybin in Normal Adults
PHASE1Withdrawn
Started: Jun 30, 2023 · Completed: Mar 31, 2024
NCT05035927Lead Sponsor
Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder
PHASE2Completed
5 participants
Started: Mar 16, 2022 · Completed: Jun 7, 2024
Related Companies
Exopharm
acquired